Sign in Create account
Sign in and upgrade to a paid plan to export price history as CSV.

Sanofi India Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: SANOFI BSE: 500674
₹3057.00
▼ -15.10 (-0.49%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
98/100
Strong
Valuation
27/100
Expensive
Momentum
46/100
Neutral

QVM read Quality business Quality Strong, Valuation Expensive, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹7,040 Cr
PE (TTM)
21.7
Industry median 36.1 (152 companies)
Price to Book
9.4
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
25.56%
FII + DII, latest filed period
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
-3.1
Relative return vs Sector, qtr %
-11.7
Free Cash Flow
₹201 Cr
as of June 30, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
20.15%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-20.60%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-6.45%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
20.14%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
7.73%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.88
as of Dec. 31, 2025
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of Dec. 31, 2025
Industry median 0.14 (186 companies)
Interest Coverage
273.19
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
19.08%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
25.73%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
24.21%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
26.04%
as of Dec. 31, 2025
Industry median 5.54% (180 companies)
Return on Capital Employed
58.48%
as of Dec. 31, 2025
Industry median 12.43% (181 companies)
Return on Equity
43.61%
as of Dec. 31, 2025
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 5 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • Yes Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • Yes Return on equity is 15% or more (43.6%)
  • No Net cash flow for the latest year is positive

Ownership

3 of 3 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.5%
Low 3051.6000 · High 3175.0000
1W return
0.2%
Low 3051.6000 · High 3220.9000
1M return
-2.1%
Low 3049.0000 · High 3220.9000
52W return
-35.0%
Low 3049.0000 · High 4898.0000
Lifetime High ₹10072.6500 (June 12, 2024)
Lifetime Low ₹1997.1500 (June 22, 2011)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
3082.3
10D
3091.6
20D
3116.2
50D
3190.7
100D
3303.2
200D
3534.5

Delivery and volume

Day avg. delivery
59.4%
Week avg. delivery
47.7%
Month avg. delivery
49.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

3094.53
Pivot
First resistance3137.47
Second resistance3217.93
Third resistance3260.87
First support3014.07
Second support2971.13
Third support2890.67
Day RSI38.3
Day MFI56.4
Day MACD-37.57
Day MACD signal-42.36

Beta

1M-0.52
3M0.22
1Y0.49
3Y0.46

Price change analysis

↓ -2.1%
Over 1 Month
LowHigh
3049.003220.90
↓ -11.7%
Over 3 Months
LowHigh
3049.003488.90
↓ -6.3%
Over 6 Months
LowHigh
3049.003609.00
↓ -35.0%
Over 1 Year
LowHigh
3049.004898.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 21.7 (own history: 23.9–38.2)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹438 Cr
Net profit (June 30, 2026)
₹84 Cr
Basic EPS (June 30, 2026)
₹36.2600

Ranks #52 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter60.40%
  • Mutual funds9.14%
  • FII/FPI5.69%
  • Other DII10.73%
  • Public14.04%

Largest holders

NameCategoryShares %Shares
HOECHST GMBHPromoter60.3700%13904722
LIFE INSURANCE CORPORATION OF INDIA - P & GS FundPublic5.9500%1369833
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUNDPublic4.0800%940234
GENERAL INSURANCE CORPORATION OF INDIAPublic2.5600%589887
ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C - ADITYA BIRLA SUN LIFE MNC FUNDPublic2.3200%534314

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 60.40% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 5.64% to 5.69% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings decreased from 9.26% to 9.14% in Jun 2026 qtr

4 mutual fund schemes also hold this stock.

All shareholding details →

Insider trading, SAST & pledges

All 0 insider trades, 11 SAST, 0 pledge events →

All insider and SAST disclosures →

Deals (Bulk & Block)

All 35 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
24 Sep 2026 SANOFI HEALTHCARE INDIA PRIVATE LIMITED Bulk Buy 3,500,000 3052.0000 NSE
24 Sep 2026 HOECHST GMBH Bulk Sell 3,500,000 3052.0000 NSE
24 Sep 2026 SANOFI HEALTHCARE INDIA PRIVATE LIMITED Block Buy 3,500,000 3052.0000 NSE
24 Sep 2026 HOECHST GMBH Block Sell 3,500,000 3052.0000 NSE
24 Sep 2026 HOECHST GMBH Bulk Sell 3,500,000 3052.0000 NSE
24 Sep 2026 SANOFI HEALTHCARE INDIA PRIVATE LIMITED Bulk Buy 3,500,000 3052.0000 NSE
12 Jun 2026 NIPPON INDIA MUTUAL FUND Bulk Buy 264,118 3150.0000 BSE
12 Jun 2026 HDFC LIFE INSURANCE COMPANY LIMITED Bulk Sell 275,000 3150.0000 BSE
17 Oct 2022 ISHARES MSCI INDIA SMALL-CAP ETF Block Buy 4,485 5743.7000 BSE
17 Oct 2022 ISHARES INDIA SC MAURITIUS COMPANY Block Sell 4,485 5743.7000 BSE

All bulk and block deals →

Dividends

Full dividend history →
Last 12 months ₹123.00 per share
Dividend yield 4.02%
Ex-dateSubjectPer share (₹)Record date
22 Apr 2026 Dividend - Rs 48 Per Share 48.0000 22 Apr 2026
7 Nov 2025 Interim Dividend - Rs 75 Per Share 75.0000 7 Nov 2025
25 Apr 2025 Dividend - Rs 117 Per Share 117.0000 25 Apr 2025
3 May 2024 Dividend - Rs 117 Per Share 117.0000 3 May 2024
7 Mar 2024 Interim Dividend - Rs 50 Per Share 50.0000 7 Mar 2024
28 Apr 2023 Final Dividend - Rs 194/ Special Dividend - Rs 183 Per Share 194.0000 —
5 Aug 2022 Special Dividend - Rs 193 Per Sh 193.0000 8 Aug 2022
12 Apr 2022 Annual General Meeting/Dividend - Rs 181 Per Share/Special Dividend - Rs 309 Per Share 181.0000 —
19 Apr 2021 Dividend - Rs 125 Per Share Special Dividend 240 Per Share 125.0000 —
29 Jun 2020 Dividend - Rs 106 Per Share Special Dividend 243 Per Share 106.0000 —

Corporate Actions

Full history (43 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from AVENTIS PHARMA LTD. to Sanofi India Ltd
—NAME_CHANGEName changed from Hoechst Marion Roussel Ltd. to Aventis Pharma Ltd.
13 Jun 2024MERGERDemerger
3 May 2024OTHERAnnual General Meeting
7 Apr 2010AGMAgm/Div-Rs.16.50 Pr Share

All corporate actions →

Board Meetings

View board meeting history →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
4 Aug 2026 Financial Results Yes
28 Apr 2026 Financial Results Yes
25 Feb 2026 Financial Results/Dividend Yes
29 Oct 2025 Financial Results/Dividend Yes
31 Jul 2025 Financial Results Yes

Corporate Announcements

All 849 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
29 Sep 2026 Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show Cause Notice from GST Authority.
29 Sep 2026 Company Update Sanofi India Ltd - 500674 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
28 Sep 2026 Insider Trading / SAST Sanofi India Ltd - 500674 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
28 Sep 2026 Disclosure under SEBI Takeover Regulations Sanofi Healthcare India Private Limited has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.
28 Sep 2026 Updates Sanofi India Limited has informed the Exchange regarding Disclosure received by the Company on 25th September 2026 under Regulation 7(2)(a) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Sanofi Healthcare India Private Limited, an entity of the Promoter Group of the Company
28 Sep 2026 Updates Sanofi India Limited has informed the Exchange regarding 'Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015'.
28 Sep 2026 Company Update Sanofi India Ltd - 500674 - Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
28 Sep 2026 Company Update Sanofi India Ltd - 500674 - Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
25 Sep 2026 Insider Trading / SAST Sanofi India Ltd - 500674 - Closure of Trading Window
25 Sep 2026 Action(s) taken or orders passed Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show Cause Notice from GST Authorities

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • High Return on Equity (43.6%)
  • Low financial leverage (Debt/Equity 0.00)
  • Comfortable interest coverage (273.2x)
  • Healthy liquidity (Current Ratio 1.88)

Weaknesses

Data unavailable.

Opportunities

Data unavailable.

Threats

  • Down 35.0% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Sanofi India Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.